Avanos Medical AVNS
NYSE AVNS
$24.99 +0.01 (+0.04%)
At close: Jul 24, 2026 · 4:03 PM EDT

Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018)

Avanos Medical (AVNS) posted Other Accumulated Expenses of $34.1 million for Q3 2018, up 16.78% sequentially from $29.2 million in Q4 2017.

Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018) Analysis & Trends

Avanos Medical has reported Other Accumulated Expenses for 2 years, with the latest figure at $34.1 million in Q3 2018.

  • Quarterly Other Accumulated Expenses changed N/A year-over-year to $34.1 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $34.1 million (changed N/A YoY) and the FY2017 annual result came in at $29.2 million, changed N/A from the prior year.
  • Other Accumulated Expenses improved to $34.1 million in Q3 2018 per AVNS's latest filing, from $29.2 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $34.1 million in Q3 2018 and troughed at $29.2 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Avanos Medical 1.17 Bn 1.10 Bn 94.20 Mn

Historic Data

Download Data
DateValue
Sep 30, 2018 34.10 Mn
Dec 31, 2017 29.20 Mn